Related Articles
Knockdown of E2F5 induces cell death via the TP53‑dependent pathway in breast cancer cells carrying wild‑type TP53
MED23 in endocrinotherapy for breast cancer
RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancer
Role of mTOR inhibitor in cholangiocarcinoma cell progression
Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway